Key malaria vaccine set for field trial

A large-scale trial of the world’s most advanced experimental malaria vaccine, Mosquirix, to give partial protection to children has begun in Malawi, Africa. In the upcoming week, the vaccine would be rolled out in Kenya and Ghana. Mosquirix has been developed by British pharmaceutical company GlaxoSmithKline in partnership with the PATH Malaria Vaccine Initiative. It… Continue reading Key malaria vaccine set for field trial